Home | Welcome to Contract Pharma   
Last Updated Friday, May 22 2015

Print

Search Results for 'tablets'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

Published May 8, 2015
The goal of this study was to design a platform technology for a controlled release orally disintegrating tablet (ODT) using cationic ion exchange resins which will facilitate taste masking. Sodium polystyrene sulfonate, USP (AMBERLITETM IRP69) was u… Read More »
Published May 8, 2015
The purpose of this study was to investigate the root cause and potential mechanism behind the areas of discoloration on stability samples of pharmaceutical tablets. The most likely mechanism of tablet discoloration was related to a dehydration react… Read More »
Published May 8, 2015
The purpose of this study is to further optimize and assess the effect of refining magnesium stearate lubricant, sweetener, hardness and thickness levels on the design of a fast disintegrating formulation by direct compression.… Read More »
Why is Good Tablet Design so Important and How to Achieve it?
By Steve Deakin and Steve Osborn , I Holland
Published May 6, 2015
Accuracy and tooling performance are essential for today’s complex profiles Read More »
Will All Tablets and Capsules Have On-Dose Physical Chemical Identifiers Soon?
By Kent Mansfield , president TruTag Technologies, Inc.
Published April 1, 2015
As the global problem of counterfeit and diverted drugs continues to grow worldwide, will our medicine soon carry secure identifiers woven into the very fabric of the drug product? Advancing technology is finally allowing drug makers the ability to implement on-dose authentication. Read More »
Solid Dosage Tablet Technologies
By Ben Locwin, Healthcare Science Advisors
Published March 6, 2015
Looking at the trends and challenges shaping the solid dosage market Read More »
Published July 28, 2010
EMD Serono’s NDA for Cladribine Tablets has accepted for filing as a therapy for relapsing forms of multiple sclerosis (MS). Read More »
Published January 2, 2007
Ranbaxy Laboratories has received approval from the FDA to manufacture and market Atenolol Tablets USP, 25 mg, 50 mg, and 100 mg. The Office of Generic Drugs, U.S. FDA, has determined the Ranbaxy formulations to be bioequivalent and have the same the… Read More »
Published February 2, 2015
Allows for expanded manufacturing and packaging services for U.S. market Read More »
Constantia Flexibles
By Fred Lutz, Regional Sales Manager North America, Segment Pharma
Constantia Flexibles offers foil-based packaging solutions to the North American pharmaceutical industry. Its products include: anti-counterfeiting security foils; push-through and peelable blister foils; cold-formable foils; heat seal coatings for P… Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On